Clinical Trials for Stage III Pancreatic Cancer AJCC v8

Find clinical trials for stage iii pancreatic cancer ajcc v8. Discover research opportunities and treatment options in your area.

19 Active Trials Found

Showing 19 trials on this page

Page 1 of 1

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

NCT ID: NCT04550494

This clinical trial is studying a medication called talazoparib to see how well it works for patients with advanced cancers that have spread in the body and have specific changes in their DNA repai...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States, Oklahoma City, Oklahoma, United States +2 more

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

NCT ID: NCT04172532

This clinical trial is studying a new anti-cancer drug called M3814 (Peposertib) to see how it works when combined with radiation therapy for patients with locally advanced pancreatic cancer. The g...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Lebanon, New Hampshire, United States +46 more

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

NCT ID: NCT06630325

The SMMART-ACT clinical trial is exploring a new way to treat patients with advanced cancers, such as sarcoma, breast, prostate, ovarian, and pancreatic cancer. This study uses a personalized appro...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Portland, Oregon, United States, Portland, Oregon, United States

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

NCT ID: NCT05685602

This clinical trial is studying a new treatment approach for patients with advanced pancreatic cancer that cannot be surgically removed or has spread to other parts of the body. The researchers are...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Bethesda, Maryland, United States +28 more

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

NCT ID: NCT05411094

This clinical trial is exploring the safety of two anti-cancer drugs, durvalumab and olaparib, in combination with radiation therapy for patients with locally advanced pancreatic cancer that cannot...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ann Arbor, Michigan, United States, Los Angeles, California, United States +12 more

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

NCT ID: NCT06381154

This clinical trial is studying a new treatment approach for patients with pancreatic cancer that cannot be surgically removed. The treatment combines a light-activated drug called verteporfin with...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States

A Phase II Nationwide, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreas Cancer With FGFR Genetic Alterations

NCT ID: NCT06906562

This clinical trial is studying a medication called Pemigatinib for adults with advanced or metastatic pancreas cancer that has specific genetic changes known as FGFR alterations. The goal is to se...

Recruiting

Phase: PHASE2 Type: interventional Locations: Columbus, Ohio, United States

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

NCT ID: NCT06626256

This clinical trial is studying a new treatment called STIL101 for injection, designed to help patients with certain types of advanced cancers, including pancreatic, colorectal, renal cell, cervica...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

NCT ID: NCT05911243

This clinical trial is looking at a treatment called auricular acupressure, which involves placing small adhesive pellets on specific points of the outer ear. Researchers want to see if this method...

Recruiting

Phase: NA Type: interventional Locations: Seattle, Washington, United States

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

NCT ID: NCT06998940

This clinical trial is investigating whether adding a medication called panitumumab to standard chemotherapy can help patients with advanced pancreatic cancer. The study is focused on patients whos...

Not yet recruiting

Phase: PHASE3 Type: interventional

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

NCT ID: NCT04484909

This clinical trial is studying a treatment called NBTXR3, which is being used together with radiation therapy to see if it can help control pancreatic cancer. Specifically, the trial is focused on...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

NCT ID: NCT04821284

This clinical trial is studying a new treatment approach for pancreatic cancer that combines standard chemotherapy with a technique called sonoporation. Sonoporation uses ultrasound waves and tiny ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bergen, , Norway, Philadelphia, Pennsylvania, United States

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

NCT ID: NCT06454383

This clinical trial is studying a combination of two medications, gemcitabine and leflunomide, to see if they can be safely used together to treat patients with advanced pancreatic cancer that cann...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas

NCT ID: NCT05053971

This clinical trial is exploring a new combination of two anti-cancer drugs, entinostat and ZEN003694, to see how safe they are and how well they work for patients with advanced solid tumors or lym...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Oklahoma City, Oklahoma, United States +2 more

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

NCT ID: NCT04005690

This clinical trial is investigating how well certain medications work for patients with pancreatic cancer, specifically those with advanced or metastatic forms of the disease. The drugs being test...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Portland, Oregon, United States

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

NCT ID: NCT04887805

This clinical trial is studying a combination of two medications, lenvatinib and pembrolizumab, to see if they can help patients with advanced pancreatic cancer that cannot be surgically removed. L...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States

Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

NCT ID: NCT05034627

This clinical trial is studying a new treatment approach for patients with locally advanced or metastatic pancreatic cancer, which means the cancer has either spread to nearby tissues or to other p...

Recruiting

Phase: PHASE1 Type: interventional Locations: Portland, Oregon, United States

Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

NCT ID: NCT04158635

This clinical trial is looking at a new treatment approach for patients with pancreatic cancer that cannot be surgically removed. The study is testing a combination of three treatments: gemcitabine...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

NCT ID: NCT05733000

This clinical trial is investigating a new treatment approach for patients with certain advanced cancers that have not responded to standard chemotherapy. The study is testing a combination of thre...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions